Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population

Diabetes Research and Clinical Practice

Volumn 72, Issue 2, 2006, Pages 170-175

  Tobon, G J ^a,b   Arango, A ^b   Abad, V ^c   Garcia J ^d   Cuervo, H ^b,d   Velasquez A ^c   Angel, I D ^d   Vega, P ^a   Abad, A ^e   Anaya, J M ^a,f  

^a Unidad de Biología Celular y Molecular   (Colombia)

^b Clinica Universitaria Bolivariana   (Colombia)

^c HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^d Antioqueña de Diabetes   (Colombia)

^e Laboratorio de Endocrinologia   (Colombia)

^f UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Colombia; GADA; IA 2A; IAA; Type 1 diabetes

Indexed keywords

ANTIBODY; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; TYROSINE PHOSPHATASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CHILD; CLINICAL FEATURE; COLOMBIA; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC KETOACIDOSIS; DISEASE DURATION; ETHNOLOGY; FEMALE; GEOGRAPHY; HUMAN; IMMUNOLOGY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ONSET AGE; QUESTIONNAIRE; RADIOIMMUNOASSAY; SEX DIFFERENCE;

ADULT; AGE OF ONSET; AUTOANTIBODIES; COLOMBIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN ANTIBODIES; MALE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33646160994     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.10.016     Document Type: Article

References (35)

1. Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., La Porte R., and Toumilehto J. Incidence of childhood type 1 diabetes worldwide. Diab. Care 23 (2000) 1516-1526
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diab. Care 20 (1997) 1183-1197.
3. Pugliese A. Genetics of type 1 diabetes. Endocrinol. Metabol. Clinics N.A. 33 (2004) 1-16
4. Ito T., Nakamura K., Umeda E., Kaino Y., Hirai H., Kida K., et al. Familial predisposition of type 1 diabetes mellitus in Japan, a country with low incidence. Japan Diabetes Society Data Committee for Childhood Diabetes. J. Pediatr. Endocrinol. Metab. 14 (2001) 589-595
5. Bravo M.L., Valenzuela C.Y., and Arcos-Burgos O.M. Polymorphisms and phyletic relationships of the Paisa community from Antioquia (Colombia). Gene. Geogr. 10 (1996) 11-17
6. Jimenez I., Mora O., Lopez G., Jimenez M.E., Zuluaga L., Isaza R., et al. Idiopathic epilepsy with generalized tonic clonic seizures in Antioquia, Colombia: is the joint Amerindian and Negroid racial admixture the cause of its high prevalence?. Biol. Res. 29 (1996) 297-304
7. In: Parsons J.J. (Ed). Antioqueño Colonization in Western Colombia (1949), Berkeley, California
8. Carvajal-Carmona L.G., Soto I.D., Pineda N., Ortiz-Barrientos D., Duque C., Ospina-Duque J., et al. Strong Amerindian/white sex bias and a possible Sephardic contribution among the founders of a population in northwest Colombia. Am. J. Hum. Genet. 67 (2000) 1287-1295
9. Hirschhorn J.N. Genetic epidemiology of type 1 diabetes. Pediat. Diab. 4 (2003) 87-100
10. Frazer de Llado T.E., Gonzalez de Pijem L., and Hawk B. Incidence of IDDM in children living in Puerto Rico. Puerto Rican IDDM Coalition. Diab. Care 5 (1998) 744-746
11. Sereday M.S., Marti M.L., Damiano M.M., and Moser M.E. Establishment of a registry of IDDM in Avellaneda, Argentina. Diab. Care 9 (1994) 1022-1025
12. Lipton R.B., and Fivecoate J.A. High risk of IDDM in African-American and Hispanic children in Chicago 1985-1990. Diab. Care 18 (1995) 476-482
13. Gunczler P., Lanes R., Layrisse Z., Esparza B., Salas R., Hernandez L., et al. Epidemiology and inmunogenetics in recently diagnosed Venezuelan children with insulin-dependent diabetes mellitus. J. Pediatr. Endocrinol. 6 (1993) 165-171
14. Marti M.L., de Sereday M.S., Damiano M., Moser M., and Varela A. Diabetes prevalence in a school population of Avellaneda, Argentina. Medicina (B Aires) 54 (1994) 110-116
15. Perez-Bravo F., Riesco V., Albala C., Oyarzun A., Santos J.L., and Carrasco E. Auto-antibody profile and breast feeding in type 1 diabetic patients. Rev. Med. Chil. 129 (2001) 611-619
16. Mijac V., Arrieta J., Mendt C., Valbuena H., and Ryder E. Role of environmental factors in the development of insulin-dependent diabetes mellitus (IDDM) in Venezuelan children. Invest. Clin. 36 (1995) 73-82
17. Leslie R.D., Atkinson M.A., and Notkins A.L. Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes. Diabetologia 42 (1999) 3-14
18. Hawa M., Rowe R., Lan M.S., Notkins A.L., Pozzilli P., Christie M.R., et al. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 48 (1997) 1270-1275
19. Hagopian W.A., Sanjeevi S.A., Kockum I., Landin-Olssen M., Karlsen A.E., Sundkvist G., et al. Glutamate decarboxylase-, insulin-, and islet cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 95 (1995) 1505-1511
20. Velloso L.A., Kampe O., Hallberg A., Christmanson L., Betsholtz C., and Karlson G.A. Demonstration of Gad-65 as the main immunogenic isoform of glutamate decarboxylase in type I diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J. Clin. Invest. 91 (1993) 2084-2090
21. Atkinson M.A., Kaufman D.L., Newman D., Tobin A.J., and Maclaren N.K. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J. Clin. Invest. 91 (1993) 350-356
22. Krochik A.G., Mazza C.S., Valdez S.N., Stumpo R.R., Papouchado M.L., Iacono R.F., et al. Immunologic and genetics markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population. Medicina (B Aires) 61 (2001) 279-283
23. Mendoza-Morfin F., Curiel-Perez M.O., Cardenas-Tirado H., Montero-Gonzalez P., Gutierrez-Avila C., Bravo-Rios L.E., et al. Frequency of glutamic acid decarboxylase autoantibodies in Mexican diabetic children. Rev. Invest. Clin. 52 (2000) 427-431
24. Nishino M., Ikegami H., Kawaguchi Y., Fujisawa T., Kawabata Y., Shintani M., et al. Polymorphism in gene for islet autoantigen, IA-2, and type 1 diabetes in Japanese subjects. Hum. Immunol. 62 (2001) 518-522
25. Hermitte L., Atlan-Gepner C., Mattei C., Dufayet D., Jannot M.F., Christofilis M.A., et al. Diverging evolution of anti-GAD and IA-2A antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications. Diab. Med. 15 (1998) 586-591
26. Verge C., Howard N., Rowley M., Mackay I., and Zimmet P. Antiglutamate decarboxylase, and other antibodies at onset of childhood IDDM: a population-based study. Diabetologia 37 (1994) 1113-1120
27. Decochez K., Tits J., Coolens J.L., Van Gaal L., Krzentowski G., Winnock F., et al. The Belgian diabetes registry: high frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. Diab. Care 23 (2000) 838-844
28. Tiberti C., Buzzetti R., Anastasi E., Dotta F., Vasta M., Petrone A., et al. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a Caucasian population: are these type 1b diabetes cases?. Diab. Metab. Res. Rev. 16 (2000) 8-14
29. Carreras G., Mauricio D., Perez A., and de Leiva A. Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?. Diab. Care 23 (2000) 1715-1716
30. Bao F., Yu L., Babu S., Wang T., Hoffenberg E.J., Rewer S.M., et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated transglutaminase autoantibodies. J. Autoimmun. 13 (1999) 143-148
31. Buysschaert M. Coeliac disease in patients with type 1 diabetes mellitus and auto-immune thyroid disorders. Acta Gastoenterol. Belg. 66 (2003) 237-240
32. Frasier S.D., Penny R., Zinder R., Goldstein I., and Graves D. Antithyroid antibodies in Hispanic patients with type I diabetes mellitus. Prevalence and significance. Am. J. Dis. Child 140 (1986) 1278-1280
33. Kordonouri O., Klinghammer A., Lang E.B., Gruters-Kieslich A., Grabert M., and Holl R.W. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diab. Care 25 (2002) 1346-1350
34. Levin L., and Tomer Y. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun. Rev. 2 (2003) 377-386
35. Gomez L.M., Anaya J.-M., Gonzalez C.I., Pineda-Tamayo R., Otero W., Arango A., and Martín J. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun. 6 (2005) 628-631